Work

Efficacy and safety of anti-FcRN treatment in refractory MG-the UK experience of the Efgartigimod EAMS

Year: 2024

Type: conference-paper

Study design: Observational Study

DOI: 10.1136/jnnp-2024-abn.224

Authors: Moniz Dionísio J, Thambirajah N, Ambrose P, Burke G, Farrugia M, Garcia-Reitboeck P, Hewamadduma C, Norwood F, Spillane J, et al

Institutions: King's College Hospital, National Hospital for Neurology and Neurosurgery, University of Nottingham, Queen's Medical Centre, Southampton General Hospital, Queen Elizabeth University Hospital, St George’s University Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404183412

FWCI:

Cites:

Cited by:

Related to: 10